Non-Muscle Invasive Bladder Cancer Overview

Save information for later
Sign Up

Learn About Non-Muscle Invasive Bladder Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Non-Muscle Invasive Bladder Cancer Local Doctors?
Urology | General Surgery
Urology | General Surgery

The Urology Center Of Colorado PC

2777 Mile High Stadium Cir, 
Denver, CO 
 8.7 mi
Offers Telehealth

Marklyn Jones is an Urologist and a General Surgeon in Denver, Colorado. Dr. Jones and is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Reconstructive Urology Surgery, and Nephrectomy.

The Urology Center Of Colorado PC

2777 Mile High Stadium Cir, 
Denver, CO 
 8.7 mi

Donald May is an Urologist in Denver, Colorado. Dr. May and is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Neurogenic Bladder, Obstructive Uropathy, Hydronephrosis, Reconstructive Urology Surgery, and Nephrectomy.

 
 
 
 
Learn about our expert tiers
Learn More
2777 Mile High Stadium Cir, 
Denver, CO 
 8.7 mi

Alexander Philpott is an Urologist in Denver, Colorado. Dr. Philpott and is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Testicular Failure, Eunuchoidism Familial Hypogonadotropic, and Vasectomy.

What are the latest Non-Muscle Invasive Bladder Cancer Clinical Trials?
A Phase I/II, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of BH011 in Subjects With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer After Bacillus Calmette-Guérin

Summary: The purpose of this study is to determine the safety and tolerability of intravesical BH011 in patients with high-risk non-muscle invasive bladder cancer(NMIBC) after Bacillus Calmette-Guerin(BCG) failure and to assess the preliminary efficacy.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Summary: This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from s...